Pilocarpine Hydrochloride Ophthalmic Solution
DEFINITION
Pilocarpine Hydrochloride Ophthalmic Solution is a sterile, buffered, aqueous solution of pilocarpine hydrochloride. It contains NLT 90.0% and NMT 110.0% of the labeled amount of pilocarpine hydrochloride (C11H16N2O2·HCl). It may contain suitable antimicrobial agents and stabilizers, and suitable additives to increase its viscosity.
IDENTIFICATION
• A.
The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
ASSAY
• Procedure
Solution A:
Ammonium hydroxide in isopropyl alcohol (1 in 50)
Mobile phase:
n-Hexane and Solution A (700:300)
Standard solution:
1.6 mg/mL of USP Pilocarpine Hydrochloride RS in water
Sample solution:
Nominally equivalent to 1.6 mg/mL of pilocarpine hydrochloride from a volume of Ophthalmic Solution diluted with methanol
Chromatographic system
Mode:
LC
Detector:
UV 220 nm
Column:
4.6-mm × 25-cm; packing L3
Flow rate:
2 mL/min
Injection size:
10 µL
System suitability
Sample:
Standard solution
[NoteThe retention time for pilocarpine hydrochloride is 16 min. ]
Suitability requirements
Relative standard deviation:
NMT 2.0% for pilocarpine hydrochloride for three replicate injections
Analysis
Samples:
Standard solution and Sample solution
Calculate the percentage of the labeled amount of pilocarpine hydrochloride (C11H16N2O2·HCl) in each mL of Ophthalmic Solution taken:
Result = (rU/rS) × (CS/CU) × 100
Acceptance criteria:
90.0%110.0%
SPECIFIC TESTS
• Sterility Tests 71:
Meets the requirements
• pH 791:
3.55.5
ADDITIONAL REQUIREMENTS
• Packaging and Storage:
Preserve in tight containers.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
USP35NF30 Page 4323
|